U.S. markets closed

Ebix, Inc. (EBIX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
28.53+1.22 (+4.47%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Slow Stochastic

Slow Stochastic

Previous Close27.31
Open28.25
Bid28.50 x 1000
Ask28.75 x 900
Day's Range27.50 - 28.95
52 Week Range17.83 - 64.14
Volume324,759
Avg. Volume756,919
Market Cap882.801M
Beta (5Y Monthly)2.71
PE Ratio (TTM)9.45
EPS (TTM)3.02
Earnings DateMay 17, 2021 - May 21, 2021
Forward Dividend & Yield0.30 (1.05%)
Ex-Dividend DateMar 01, 2021
1y Target Est40.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
16% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Ebix Hosts Q1 Investor Call Monday, May 17th at 11:00 a.m. ET
    GlobeNewswire

    Ebix Hosts Q1 Investor Call Monday, May 17th at 11:00 a.m. ET

    JOHNS CREEK, Ga., May 14, 2021 (GLOBE NEWSWIRE) -- Ebix, Inc. (NASDAQ: EBIX), a leading international supplier of On-Demand software and E-commerce services to the insurance, financial, healthcare and e-learning industries today announced that the Company will report its 2021 first quarter results on Monday, May 17th, 2021, and will host an investor conference call at 11:00 am ET on the same day to discuss the Company's performance. The call is open to the public. Conference Call, Webcast and Replay Details:Call Date/Time: May 17, 2021 at 11:00 a.m. ETCall Dial-In Toll Free: +1 (877) 837-3909International Dial-In: +1 (973) 409-9690Call ID: # 9598823 Live Audio Webcast: https://www.ebix.com/webcast Audio Replay URL: http://www.ebix.com/result_21_q1 after 2:00 p.m. About EbixWith 50+ offices across 6 continents, Ebix, Inc., (NASDAQ: EBIX) endeavors to provide On-Demand software and E-commerce services to the insurance, financial, healthcare and e-learning industries. In the Insurance sector, Ebix’s main focus is to develop and deploy a wide variety of insurance and reinsurance exchanges on an on-demand basis, while also providing Software-as-a-Service ("SaaS") enterprise solutions worldwide in the area of CRM, front-end & back-end systems, outsourced administration and risk compliance services. For more information please visit the Company’s website at www.ebix.com With a "Phygital” strategy that combines 320,000 physical distribution outlets in many Southeast Asian Nations (“ASEAN”) countries to an omni-channel online digital platform, the Company’s EbixCash Financial exchange portfolio encompasses leadership in areas of domestic & international money remittance, foreign exchange (Forex), travel, pre-paid & gift cards, utility payments, lending, wealth management etc. in India and other international markets. EbixCash’s Forex operations have emerged as a leader in India’s airport Foreign Exchange business, conducting over $4.8 billion in annual gross transaction value in 32 international airports, including Delhi, Mumbai, Bangalore, Hyderabad, Chennai and Kolkata. EbixCash’s inward remittance business in India conducts approximately $6.5 billion of gross annual remittance volume, confirming its undisputed leadership position in India. EbixCash, through its travel portfolio of Via and Mercury, is also one of Southeast Asia’s leading travel exchanges with over 2,200+ employees, a 212,450+ agent network, 25 branches and over 9,800 corporate clients. EbixCash Travel processes an estimated $2.5 billion in gross merchandise value per year. Visit the Company’s website at www.ebixcash.com CONTACT:Darren Joseph or Gautam Sharma678 -281-2027 or IR@ebix.com David Collins or Chris EddyCatalyst Global - 212-924-9800 or ebix@catalyst-ir.com

  • Here’s Why Ebix Inc. (EBIX) Landed in Wasatch Global’s Detractor List
    Insider Monkey

    Here’s Why Ebix Inc. (EBIX) Landed in Wasatch Global’s Detractor List

    Wasatch Global Investors, an investment management firm, published its “Wasatch Small Cap Value Fund” first quarter 2021 investor letter – a copy of which can be downloaded here. A return of 15.42% was recorded by the fund’s investor class for the Q1 of 2021, trailing the benchmark, Russell 2000® Value Index, that rose to 21.17% for […]

  • Bragar Eagel & Squire is Investigating Certain Officers and Directors of Merit Medical Systems, Ebix, Inc., and Zoom on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    GlobeNewswire

    Bragar Eagel & Squire is Investigating Certain Officers and Directors of Merit Medical Systems, Ebix, Inc., and Zoom on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

    NEW YORK, May 04, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors of Merit Medical Systems, Inc. (NASDAQ: MMSI), Ebix, Inc. (NASDAQ: EBIX), and Zoom Video Communications, Inc. (NASDAQ: ZM) on behalf of long-term stockholders. More information about each potential case can be found at the link provided. Merit Medical Systems, Inc. (NASDAQ: MMSI) Bragar Eagel & Squire is investigating certain officers and directors of Merit Medical Systems, Inc. following news that the Shareholder Class Action against Merit Medical has survived the motions to dismiss in the pending securities class action and may face damages. According to the securities class action complaint, during the class period defendants made false and misleading statements and/or failed to disclose adverse information concerning Merit’s business and prospects. Specifically, defendants failed to disclose that: (a) the integrations of Cianna and Vascular Insights, including their products, sales people, and R&D facilities, had caused operational disruptions and reduced sales and were months behind schedule; (b) sales of acquired company products had slowed substantially due to pre-acquisition pipeline fill, in particular for Vascular Insights products which, as late as July 2019, had zero orders during fiscal 2019; and (c) in light of the foregoing, the Company’s reported financial guidance for fiscal 2019 and 2020 was made without a reasonable basis. As a result of defendants’ material misrepresentations and omissions, Merit stock traded at artificially inflated prices of more than $62 per share. On March 29, 2021, U.S. District Judge David O. Carter denied defendants’ motions to dismiss plaintiffs’ claims, finding that plaintiffs had plausibly alleged securities fraud claims. For more information on our investigation into Merit Medical go to: https://bespc.com/cases/mmsi Ebix, Inc. (NASDAQ: EBIX) Bragar Eagel & Squire is investigating certain officers and directors of Ebix, Inc.. following a class action complaint that was filed against Ebix on February 22, 2021. The complaint alleges that throughout the Class Period defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, defendants failed to disclose to investors: (1) that there was insufficient audit evidence to determine the business purpose of certain significant unusual transactions in Ebix’s gift card business in India during the fourth quarter of 2020; (2) that there was a material weakness in Company’s internal controls over the gift or prepaid revenue transaction cycle; and (3) that the Company’s independent auditor was reasonably likely to resign over disagreements with Ebix regarding $30 million that had been transferred into a commingled trust account of Ebix’s outside legal counsel; and (4) that, as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. For more information on our investigation into Ebix go to: https://bespc.com/cases/ebix Zoom Video Communications, Inc. (NASDAQ: ZM) Bragar Eagel & Squire is investigating certain officers and directors of Zoom Video Communications, Inc. following a class action complaint that was filed against Zoom on April 7, 2020. The Complaint alleges that throughout the Class Period defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (i) Zoom had inadequate data privacy and security measures; (ii) contrary to Zoom’s assertions, the Company’s video communications service was not end-to-end encrypted; (iii) as a result of all the foregoing, users of Zoom’s communications services were at an increased risk of having their personal information accessed by unauthorized parties, including Facebook; (iv) usage of the Company’s video communications services was foreseeably likely to decline when the foregoing facts came to light; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times. For more information on our investigation into Zoom go to: https://bespc.com/cases/ZM About Bragar Eagel & Squire, P.C.:Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes. Contact Information:Bragar Eagel & Squire, P.C.Brandon Walker, Esq. Melissa Fortunato, Esq.Marion Passmore, Esq.(212) 355-4648investigations@bespc.comwww.bespc.com